View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Alphatec Holdings Inc: 1 director

A director at Alphatec Holdings Inc sold 37,500 shares at 12.820USD and the significance rating of the trade was 59/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years c...

Remitly Global Inc: 1 director

A director at Remitly Global Inc sold 20,832 shares at 18.150USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...

Huuuge Inc: 4 directors

Four Directors at Huuuge Inc sold/bought 3,447,155 shares at 25.159PLN. The significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

L''Oreal: 1 director

A director at L'Oreal sold 10,000 shares at 440.894EUR and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showin...

Bunzl: 2 directors

Two Directors at Bunzl sold after exercising options/bought/maiden bought 34,244 shares at between 3,050p and 3,062p. The significance rating of the trade was 86/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the...

Essity Aktiebolag (publ): 1 director

A director at Essity Aktiebolag (publ) maiden bought 1,607 shares at 263.750SEK and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last...

Roblox Corp: 1 director

A director at Roblox Corp sold 13,000 shares at 35.081USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sho...

Visa Inc: 1 director

A director at Visa Inc sold 909 shares at 275.547USD and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing ...

 PRESS RELEASE

Ideanomics Announces Receipt of Notice from Nasdaq Regarding Listing R...

Ideanomics Announces Receipt of Notice from Nasdaq Regarding Listing Rule 5250(f) New York, April 26, 2024 (GLOBE NEWSWIRE) -- NEW YORK, NY April 26, 2024 / Ideanomics (NASDAQ:IDEX) ("Ideanomics" or the "Company") today announced that on April 22, 2024, the Company received a notice from the staff of the Nasdaq Listing Qualifications department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") stating that it has not paid certain fees required by Listing Rule 5250(f) and the Company was not in compliance with Nasdaq Listing Rules for continued listing. The company subsequently paid ...

Lee & Ogle Counties SD 170 (Dixon), IL: Update following upgrade to A1

Our credit view of Dixon SD 170 reflects a solid financial position, solid local economy with declining enrollment, and moderate leverage.

Auburn University, AL: Update to credit analysis

Our credit view of this issuer reflects its strong operating and capital support from state of Alabama, offset by its high leverage metrics.

Town of North Reading, MA: Update to credit analysis

Our credit view reflecting improving financials, growing tax base, and moderate long term liabilities.

 PRESS RELEASE

Appili Therapeutics Announces Additional Bridge Loan from Bloom Burto...

Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co. NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES HALIFAX, Nova Scotia, April 26, 2024 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “Company” or “Appili”), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000 (the “Bridge Loan”) from Bloom Burton & Co. Inc. (the “Lender”). The Bridge Loan evi...

Reset: Magnetite XVII, Limited: New Issue Report

This new issue report provides a detailed rating rationale for the transaction.

 PRESS RELEASE

Paul Mueller Company Announces an Increase in the Share Repurchase Pro...

Paul Mueller Company Announces an Increase in the Share Repurchase Program SPRINGFIELD, Mo., April 26, 2024 (GLOBE NEWSWIRE) -- The Paul Mueller Company (OTC: MUEL) today announced that in accordance with the share tender offer announced on March 15, 2024, it will purchase shares up to the Maximum Aggregate Purchase Price of $15 million. As of April 26, 2024, Computershare, the Depository for the tender offer, has received tender requests for $5.88 million of shares at $80 a share. The tender offer ends on May 7, 2024 at 5:00 CDT. Contact Info:  Ken Jeffries  (417) 575-9000   

 PRESS RELEASE

Paul Mueller Company Announces Its First Quarter Earnings of 2024

Paul Mueller Company Announces Its First Quarter Earnings of 2024 SPRINGFIELD, Mo., April 26, 2024 (GLOBE NEWSWIRE) -- Paul Mueller Company (OTC: MUEL) today announced earnings for the quarter ended March 31, 2024. PAUL MUELLER COMPANYTHREE-MONTH REPORT(In thousands)         CONSOLIDATED STATEMENTS OF INCOME           Three Months Ended Twelve Months Ended  March 31 March 31  2024 2023 2024 2023         Net Sales $50,356 $56,351 $223,161 $207,096Cost of Sales 34,560 39,554 153,631 159,979Gross Profit $15,796 $16,797 $69,530 $47,117Selling, General and Administrative Expense10,358 12,587 8...

 PRESS RELEASE

Almaden Files Form 20-F Documentation

Almaden Files Form 20-F Documentation VANCOUVER, British Columbia, April 26, 2024 (GLOBE NEWSWIRE) -- Almaden Minerals Ltd. (“Almaden” or “the Company”; TSX: AMM; (OTCQB: AAUAF) announces that its Annual Report on Form 20-F for the fiscal year ended December 31, 2023 has been filed with the U.S. Securities and Exchange Commission. The Form 20-F and the Company's audited consolidated financial statements for the years ended December 31, 2023, 2022 and 2021 are available on the Company's website at . Shareholders of the Company may also request a hard copy of the Company's audited financia...

Tomi Railo
  • Tomi Railo

Kemira (Buy, TP: EUR23.00) - Strength continues

We have raised our 2024–2026e clean EPS by c9% on average and target price to EUR23 (21). We reiterate our BUY. We continue to see Kemira’s market exposures, earnings quality, and valuation as attractive.

Intrum AB (publ): Update following CFR downgrade to B3 and debt rating...

Our credit view of this issuer reflects its high leverage, refinancing challenges and increased risk of losses to bondholders that could result from the debt restructuring.

Virginia Polytechnic Inst. & State Univ., VA: Update to credit analysi...

Our credit view of this issuer reflects its strong brand and sizeable scope of operations offset by modest EBIDA margins, wealth and liquidity relative to peers

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch